These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9453378)

  • 1. Hyporeactivity of neonatal platelets is not caused by preactivation during birth.
    Grosshaupt B; Muntean W; Sedlmayr P
    Eur J Pediatr; 1997 Dec; 156(12):944-8. PubMed ID: 9453378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-surface glycoproteins in healthy and preeclamptic mothers and their newborn infants.
    Kühne T; Ryan G; Blanchette V; Semple JW; Hornstein A; Mody M; Chang W; McWhirter L; Freedman J
    Pediatr Res; 1996 Dec; 40(6):876-80. PubMed ID: 8947966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface expression of major membrane glycoproteins on resting and TRAP-activated neonatal platelets.
    Simák J; Holada K; Janota J; Stranák Z
    Pediatr Res; 1999 Oct; 46(4):445-9. PubMed ID: 10509366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet hyporeactivity in very low birth weight neonates.
    Rajasekhar D; Barnard MR; Bednarek FJ; Michelson AD
    Thromb Haemost; 1997 May; 77(5):1002-7. PubMed ID: 9184418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal platelets from cord blood and peripheral blood.
    Sitaru AG; Holzhauer S; Speer CP; Singer D; Obergfell A; Walter U; Grossmann R
    Platelets; 2005; 16(3-4):203-10. PubMed ID: 16011965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy.
    Kéreveur A; Callebert J; Humbert M; Hervé P; Simonneau G; Launay JM; Drouet L
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2233-9. PubMed ID: 11031209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
    Schneider DJ; Taatjes DJ; Sobel BE
    Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activation markers and the primary antiphospholipid syndrome (PAPS).
    Joseph JE; Harrison P; Mackie IJ; Machin SJ
    Lupus; 1998; 7 Suppl 2():S48-51. PubMed ID: 9814673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiated reactivity of whole blood neonatal platelets to various agonists.
    Pietrucha T; Wojciechowski T; Greger J; J drzejewska E; Nowak S; Chrul S; Golański J; Watala C
    Platelets; 2001 Mar; 12(2):99-107. PubMed ID: 11297038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant.
    Mody M; Lazarus AH; Semple JW; Freedman J
    Transfus Med; 1999 Jun; 9(2):147-54. PubMed ID: 10354385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric assay of platelet glycoprotein receptor numbers in hypercholesterolemia.
    Ozsavci D; Yardimci T; Demirel GY; Demiralp E; Uras F; Onder E
    Platelets; 2002 Jun; 13(4):223-9. PubMed ID: 12189024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood.
    Rajasekhar D; Kestin AS; Bednarek FJ; Ellis PA; Barnard MR; Michelson AD
    Thromb Haemost; 1994 Dec; 72(6):957-63. PubMed ID: 7740470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiopulmonary bypass leads to a preferential loss of activated platelets. A flow cytometric assay of platelet surface antigens.
    Wahba A; Black G; Koksch M; Rothe G; Preuner J; Schmitz G; Birnbaum DE
    Eur J Cardiothorac Surg; 1996; 10(9):768-73. PubMed ID: 8905280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Platelet membrane glycoproteins in thrombocytapheresis and platelet concentrates].
    Dittmann J; Riggert J; Wieding JU; Simson G; Köhler M
    Beitr Infusionsther Transfusionsmed; 1994; 32():422-7. PubMed ID: 9480137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of heparin, protamine, and heparinase 1 on platelets in vitro using whole blood flow cytometry.
    Kozek-Langenecker SA; Mohammad SF; Masaki T; Kamerath C; Cheung AK
    Anesth Analg; 2000 Apr; 90(4):808-12. PubMed ID: 10735780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression patterns of platelet membrane glycoprotein in healthy adults].
    Huang F; Liu R; Liu L
    Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):465-7. PubMed ID: 11721409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic redistribution of major platelet surface receptors after contact-induced platelet activation and spreading. An immunoelectron microscopy study.
    Kieffer N; Guichard J; Breton-Gorius J
    Am J Pathol; 1992 Jan; 140(1):57-73. PubMed ID: 1309961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules.
    Konijnenberg A; Stokkers EW; van der Post JA; Schaap MC; Boer K; Bleker OP; Sturk A
    Am J Obstet Gynecol; 1997 Feb; 176(2):461-9. PubMed ID: 9065199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Effects of Ranibizumab and Bevacizumab on Platelet Activation Profile.
    Sobolewska B; Grimmel C; Gatsiou A; Sopova K; Klein J; Biedermann T; Stellos K; Ziemssen F
    Ophthalmologica; 2015; 234(4):195-210. PubMed ID: 26305017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of neonatal platelets to nitric oxide in vitro.
    Keh D; Kürer I; Dudenhausen JW; Woltmann W; Falke KJ; Gerlach H
    Intensive Care Med; 2001 Jan; 27(1):283-6. PubMed ID: 11280649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.